Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oxaliplatin”

1,382 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,382 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Testing effectiveness (Phase 2)UnknownNCT01090505
What this trial is testing

Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 160
Testing effectiveness (Phase 2)Looking for participantsNCT06732856
What this trial is testing

A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer

Who this might be right for
Stomach NeoplasmGastric (Stomach) Cancer
Asan Medical Center 57
Not applicableUnknownNCT01208545
What this trial is testing

Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs

Who this might be right for
ChemotherapyNerve DegenerationNerve Conduction
NeuroMetrix, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT00263354
What this trial is testing

Oxaliplatin in Gastric Cancer

Who this might be right for
Stomach Neoplasms
Sanofi 20
Early research (Phase 1)WithdrawnNCT04270929
What this trial is testing

Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Roger Williams Medical Center
Testing effectiveness (Phase 2)UnknownNCT00363831
What this trial is testing

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
The University of Hong Kong 42
Testing effectiveness (Phase 2)Ended earlyNCT02392377
What this trial is testing

Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy

Who this might be right for
Stage IB Esophageal AdenocarcinomaStage IIA Esophageal AdenocarcinomaStage IIB Esophageal Adenocarcinoma+3 more
Case Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT00508872
What this trial is testing

Folfox-B Study for Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases
M.D. Anderson Cancer Center 2
Large-scale testing (Phase 3)Study completedNCT03366272
What this trial is testing

Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients

Who this might be right for
Lymphoma, Non-Hodgkin
Universität des Saarlandes 348
Testing effectiveness (Phase 2)WithdrawnNCT04282590
What this trial is testing

Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Study)

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Toray Industries, Inc
Testing effectiveness (Phase 2)Looking for participantsNCT05806931
What this trial is testing

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Rutgers, The State University of New Jersey 50
Large-scale testing (Phase 3)Looking for participantsNCT05314998
What this trial is testing

Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature

Who this might be right for
Pancreatic Ductal Adenocarcinoma
John Neoptolemos 394
Testing effectiveness (Phase 2)Study completedNCT00408564
What this trial is testing

Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
Medical University of South Carolina 39
Testing effectiveness (Phase 2)Study completedNCT01243775
What this trial is testing

BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Chonnam National University Hospital 33
Post-approval studies (Phase 4)Not Yet RecruitingNCT07829757
What this trial is testing

Zolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With Gastric Cancer

Who this might be right for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more
Astellas Pharma Global Development, Inc.
Testing effectiveness (Phase 2)Study completedNCT00260611
What this trial is testing

Study of Oxaliplatin and Taxotere in Prostate Cancer

Who this might be right for
Prostate Cancer
University of Pittsburgh 34
Testing effectiveness (Phase 2)Study completedNCT03111732
What this trial is testing

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaBile Duct Cancer+2 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)UnknownNCT04617457
What this trial is testing

Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic CancerMetastasisSurgery+1 more
University of Cologne 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT07090031
What this trial is testing

Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer

Who this might be right for
EFSpCR Rate
Qingdao Central Hospital 49
Next Page
50